Please login to the form below
3
Revenue 2017MabThera/Rituxan
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. MabThera/Rituxan was produced by Roche.
Roche faces prospect of second Rituxan biosimilar in US
The US Food and Drug Administration (FDA) has started its review of a second biosimilar rival to Roche's blockbuster immunotherapy drug Rituxan, with Novartis' Sandoz unit seeking to dent its ... Rituxan is used to treat blood cancers including
Kite files first CAR-T candidate in Europe
cytokine-release syndrome (CRS), which can be fatal if not managed but has also been seen with antibody therapies such as Roche's MabThera (rituximab).
Ocrevus off to a flying start as Roche raises 2017 forecasts
Roche's mainstay biologic cancer therapies also held up well in the face of biosimilar competition in some markets, with Herceptin (trastuzumab) and MabThera/Rituxan (rituximab) both gaining 3% to
NICE backs Cancer Drugs Fund support for Roche's Gazyvaro
on Roche's MabThera (rituximab) - and as monotherapy for maintenance thereafter - via the CDF. ... Like MabThera, Gazyvaro targets the CD20 receptor but has been designed with sugar molecule side chains that improve its therapeutic and safety profile.
Standing out in a crowd
Celltrion’s current focus, he said, is immunology and oncology. With biosimilars of Remicade and Mabthera already approved in Europe, the next in line for a licence is likely to be ... versions of MabThera and Herceptin.
[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Client Partner, Healthcare Brand Communications, London
-
Highly competitive package
- Account Director, Healthcare Communications
-
Salary TBC
- Publications Director, Medical Communications agency, Oxford
-
Competitive Salary
- Publications Director, Medical Communications agency, Home Based...
-
Competitive Salary
- Publications Director, Medical Communications agency, Cambridge
-
Competitive Salary
- Strategic Associate Director Healthcare PR, London
-
Substantiel package
Subscribe to our email news alerts
- We are Gold! Porterhouse Medical Group is recognised as an ‘Investor in People’ at the Gold level
- Illumina sets up first ex-US accelerator site in Cambridge
- Kisqali combination follows Verzenio onto Cancer Drugs Fund
- Genentech taps into Sosei Heptares GPCR expertise with $1bn alliance
- ACPs to lead gene therapies in haemophilia market growth
- FDA starts speedy review of Novartis’ sickle cell antibody
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Precision paediatrics: Treating patients with CAR-T
- Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
- What does it mean to be an agile organisation
- We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
- Battling breast cancer with precision medicine (Part 2)
- Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...
Quick links
Infographics
